fast track

Boehringer, Lilly’s Jardiance ties to match AZ’s Farxiga with heart failure label
Boehringer, Lilly’s Jardiance ties to match AZ’s Farxiga with heart failure label
Pharmaforum
Boehringer Ingelheim
Eli Lilly
Jardiance
FDA
heart failure
fast track
Flag link:
Rilzabrutinib granted FDA fast track designation for treatment of immune thrombocytopenia
Rilzabrutinib granted FDA fast track designation for treatment of immune thrombocytopenia
Pharmaceutical Business Review
rilzabrutinib
fast track
FDA
Sanofi
Principia Biopharma
chronic immune thrombocytopenia
Flag link:
Novavax to Start Phase III COVID-19 Trials in U.S. with Fast Track Designation
Novavax to Start Phase III COVID-19 Trials in U.S. with Fast Track Designation
BioSpace
Novavax
clinical trials
vaccines
COVID-19
fast track
FDA
Flag link:
Xeris Pharmaceuticals granted fast track designation by FDA for novel concentrated diazepam formulation for injection
Xeris Pharmaceuticals granted fast track designation by FDA for novel concentrated diazepam formulation for injection
Pharmaceutical Business Review
Xeris Pharmaceuticals
acute repetitive seizures
XP-0863
FDA
diazepam
fast track
Flag link:
FDA Grants Fast Track Designation to Pfizer's DMD Gene Therapy
FDA Grants Fast Track Designation to Pfizer's DMD Gene Therapy
BioSpace
Pfizer
fast track
FDA
Duchenne Muscular Dystrophy
PF-06939926
Flag link:
FDA fast-tracks AbbVie’s spinal injury drug
FDA fast-tracks AbbVie’s spinal injury drug
Pharmaforum
AbbVie
spinal injury
FDA
fast track
elezanumab
Flag link:
Rocket Pharmaceuticals receives FDA fast track designation for RP-L401 gene therapy for infantile malignant osteopetrosis
Rocket Pharmaceuticals receives FDA fast track designation for RP-L401 gene therapy for infantile malignant osteopetrosis
Pharmaceutical Business Review
Rocket Pharmaceuticals
FDA
fast track
RP-L401
gene therapy
infantile malignant osteopetrosis[]
Flag link:
Sarepta Therapeutics Gets Fast-Track FDA Review For Muscular Dystrophy Drug
Sarepta Therapeutics Gets Fast-Track FDA Review For Muscular Dystrophy Drug
Investors Business Daily
Sarepta Therapeutics
FDA
fast track
Duchenne Muscular Dystrophy
casimersen
Flag link:
Pfizer and BioNTech Get "Fast Track" Designation for 2 COVID-19 Vaccines
Pfizer and BioNTech Get "Fast Track" Designation for 2 COVID-19 Vaccines
Motley Fool
Pfizer
BioNTech
FDA
fast track
vaccines
COVID-19
Flag link:
FDA ‘Fast Tracks’ First Coronavirus Vaccine From Moderna
FDA ‘Fast Tracks’ First Coronavirus Vaccine From Moderna
Forbes
FDA
fast track
Moderna Therapeutics
vaccines
COVID-19
Flag link:
EMA details new drug supply monitoring system for COVID-19
EMA details new drug supply monitoring system for COVID-19
RAPS.org
EMA
Europe
COVID-19
fast track
Flag link:
Alnylam's vutrisiran gets fast-track treatment at the FDA
Alnylam's vutrisiran gets fast-track treatment at the FDA
Fierce Biotech
Alnylam
RNAi
FDA
hATTR
vutrisiran
fast track
Flag link:
IVERIC bio announces fast track designation from US FDA for Zimura to treat geographic atrophy secondary to dry age-related macular degeneration
IVERIC bio announces fast track designation from US FDA for Zimura to treat geographic atrophy secondary to dry age-related macular degeneration
Pharmaceutical Business Review
Iveric Bio
FDA
Zimura
fast track
dry age-related macular degeneration
Flag link:
Novavax Wins Fast-Track Designation for Flu Vaccine
Novavax Wins Fast-Track Designation for Flu Vaccine
Motley Fool
Novavax
flu vaccines
vaccines
NanoFlu
FDA
fast track
Flag link:
Dermira secures FDA fast track status for lebrikizumab in atopic dermatitis
Dermira secures FDA fast track status for lebrikizumab in atopic dermatitis
Pharmaceutical Business Review
Demira
atopic dermatitis
FDA
fast track
Flag link:
FDA grants fast track status to Terns’s FXR agonist to treat NASH
FDA grants fast track status to Terns’s FXR agonist to treat NASH
Pharmaceutical Business Review
Terns Pharmaceuticals
FDA
NASH
TERN-101
fast track
Flag link:
FDA grants fast track status to Moderna’s mRNA therapeutic to treat propionic acidemia
FDA grants fast track status to Moderna’s mRNA therapeutic to treat propionic acidemia
Pharmaceutical Business Review
Moderna Therapeutics
mRNA-3927
propionic acidemia
fast track
FDA
Flag link:
FDA grants fast track status to Annexon’s ANX005 to treat Guillain-Barré Syndrome
FDA grants fast track status to Annexon’s ANX005 to treat Guillain-Barré Syndrome
Pharmaceutical Business Review
Annexon
fast track
FDA
ANX005
Guillain-Barré Syndrome
Flag link:
AstraZeneca diabetes drug granted fast track status for heart failure treatment
AstraZeneca diabetes drug granted fast track status for heart failure treatment
Yahoo/Reuters
AstraZeneca
Farxiga
heart failure
diabetes
FDA
fast track
Flag link:
U.S. FDA gives fast track status to AstraZeneca's diabetes drug Farxiga
U.S. FDA gives fast track status to AstraZeneca's diabetes drug Farxiga
Yahoo/Reuters
AstraZeneca
Farxiga
chronic kidney disease
FDA
fast track
Flag link:

Pages